Semnur Files SEC Form D, Notice Of Exempt Offering Of Securities

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Semnur Pharmaceuticals, Inc. (Form D) was posted on August 15, 2013.

There was one document filed with this form. The SEC file number is 0001584541-13-000001.

The contact information for this company is 849 AVERY DRIVE, MOUNTAIN VIEW CA 94043, (847) 612-9284.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC